ARLINGTON, Va., Sept. 12, 2014 (GLOBE NEWSWIRE) -- FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced today the hiring of Margery Fischbein as Senior Managing Director, Group Head of Healthcare Investment Banking. Ms. Fischbein will be located in FBR's New York office.
"As one of the most active sectors of the American economy, the healthcare industry is a priority for FBR and we are extremely pleased Margery agreed to lead our healthcare banking practice," said Kenneth Slosser, Executive Vice President and Head of Investment Banking for FBR. "She brings a wealth of experience in sourcing and executing successful transactions in this space and adding value to issuer clients. With Margery's relationships and leadership in banking, coupled with our existing research and trading platform, we are confident we will quickly become a key player in the healthcare sector."
Margery comes to FBR from JMP Securities where she was a Managing Director in their life sciences practice. Margery was previously a Managing Director in investment banking at Citigroup and JP Morgan Chase and a Senior Vice President in investment banking at Lehman Brothers. She has also held senior industry positions as head of Corporate Development at ImClone Systems and Human Genome Sciences.
FBR & Co. (Nasdaq:FBRC) provides investment banking, merger and acquisition advisory, institutional brokerage, and research services through its subsidiary FBR Capital Markets & Co. FBR focuses capital and financial expertise on the following industry sectors: consumer; diversified industrials; energy & natural resources; financial institutions; healthcare; insurance; real estate; and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices throughout the United States. For more information, please visit www.fbr.com.
Source:FBR & Co.